FHTX vs NTRS · rev $19.3M vs P/E 18, rev $2.69B
Foghorn Therapeutics Inc (FHTX) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Latest reported FHTX revenue for 2026-06-30 was $19.3M. Net income was -$27.1M. FHTX currently screens at market cap $237.8M.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
FHTX currently screens at market cap $237.8M. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the FHTX and NTRS stock pages for the full models.
Not investment advice.